Novozymes A/S (NSIS-B.CO)
457.70 DKK -0.82%
Novozymes A/S fell 0.82% in the latest session, at 457.70 DKK. By market cap it is number 1 of the 4 consumer & materials stocks on the C25 heatmap. Its trailing P/E of 45.0 is above the median of those peers (13.9). The price is 4.9% below its 52-week high.
Key numbers
- Price
- 457.70 DKK
- Day change
- -0.82% (-3.80)
- Market cap
- 213B DKK
- P/E (trailing)
- 45.0
- P/E (forward)
- 25.4
- Dividend yield
- 1.43%
- 50-day average
- 443.70
- 200-day average
- 404.99
- 52-week range
- 336.80 – 481.50
- Dividend per share (annual)
- 6.60 DKK
Data as of 3 Nov 2026, 16:59 CET. Market data may be delayed.
Novozymes A/S over the past year
From daily closing prices. The highest close in the period was 481.50 DKK on 23 Oct 2026, the lowest 342.00 DKK on 19 Mar 2026.
| 1 month | 3 months | 6 months | Year to date | 1 year |
|---|---|---|---|---|
| +10.94% | +11.82% | +15.69% | +13.17% | +19.13% |
| Month | Close (DKK) | Change |
|---|---|---|
| November 2026 | 461.50 | -0.11% |
| October 2026 | 462.00 | +10.13% |
| September 2026 | 419.50 | -9.28% |
| August 2026 | 462.40 | +9.57% |
| July 2026 | 422.00 | +2.20% |
| June 2026 | 412.90 | +10.85% |
| May 2026 | 372.50 | -4.71% |
| April 2026 | 390.90 | +2.20% |
| March 2026 | 382.50 | +1.86% |
| February 2026 | 375.50 | -2.64% |
| January 2026 | 385.70 | -5.42% |
| December 2025 | 407.80 | +1.54% |
Consumer & materials peers
Novozymes A/S is on the C25 heatmap (Consumer & materials). How it compares with the other consumer & materials stocks there, by market cap:
| Company | Today | Market cap | P/E |
|---|---|---|---|
| Novozymes A/S NSIS-B.CO | -0.82% | 213B DKK | 45.0 |
| Carlsberg A/S CARL-B.CO | -0.50% | 132B DKK | 20.8 |
| Pandora A/S PNDORA.CO | -1.57% | 62.0B DKK | 12.3 |
| Royal Unibrew A/S RBREW.CO | +0.62% | 21.4B DKK | 13.9 |
More on NSIS-B
Open NSIS-B.CO in zysk for the live chart, news, earnings and dividends, and ask the AI why it moved: it answers in a few lines with sources and a chart (how zysk's AI stock research works). zysk explains facts, news and risks; it is not investment advice.